Trial Profile
A Phase II, Randomized, Double-blind, Placebo Controlled, Proof of Concept Study to Investigate the Safety and Efficacy of the Esflurbiprofen Hydrogel Patch in Treatment of Acute Pain Associated With Ankle Injury
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Oct 2021
Price :
$35
*
At a glance
- Drugs Esflurbiprofen (Primary)
- Indications Pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Teikoku Seiyaku
- 11 Oct 2021 Status changed from not yet recruiting to discontinued due to lack of patients number.
- 14 Apr 2016 New trial record